Pharma Pricing & Market Access Innovation Summit 2025 | GlobalBSG | 12 November 2025 | TBA, Madrid

This event 2025 is a premier industry event. It brings together global leaders in pharmaceutical pricing, market access, health economics, and reimbursement to tackle the latest challenges and opportunities in the sector. With 100+ expert speakers and attendees, the summit offers a platform for knowledge sharing, collaboration, and networking across the pharmaceutical, biotech, payer, and regulatory communities.

Amid growing pressure for affordability and value-driven care, the summit serves as a platform to discuss sustainable pricing models, patient-centric access strategies, and digital innovation in reimbursement processes.

The event highlightens the urgent need for cross-stakeholder collaboration, transparency, and the integration of digital health technologies to reshape access pathways. Participants will leave with actionable insights and strategic approaches to balance innovation, value, and accessibility in a rapidly changing healthcare landscape.

Key Topics

EU HTA Implementation:
• Impacts of the EU Health Technology Assessment regulation on market access strategies.

Innovative Pricing Models:
• Including outcomes-based pricing, subscription models, and managed entry agreements.

Global Access and Equity:
• Strategies to improve access in emerging markets and underserved regions.

Real-World Evidence (RWE) & Data Use:
• Enhancing pricing decisions and HTA submissions with real-world data.

Digital Health & Innovation:
• The role of digital tools in market access and patient outcomes.

Rare Diseases & Orphan Drugs:
• Navigating the unique pricing and access challenges in rare disease treatments.

Health Economics & Value Frameworks:
• Evolving value assessments and cost-effectiveness evaluations.

Patient-Centered Access:
• Incorporating patient perspectives in access planning and value demonstration.

Policy Trends & Regulation:
• Navigating international pricing reforms and evolving policy landscapes.

Who Should Attend?

CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

• Business Development
• Marketing
• Sales
• Pricing
• Market Access
• Medical Director
• Marketing Intelligence
• Drug Pricing
• Product Launch
• Health Economics
• Pricing Policy
• Product Reimbursement
• Health Technology
• Assessment
• Real World Evidence
• Health Informatics
• Data Sciences
• Value Strategy
• P&MA
• Tendering

Target Audience:
• International and regional health authorities and regulators
• Pharmaceutical, Vaccines, & Biotechnology companies
• Clinical Research Organization (CRO) service providers
• Business Process Outsourcing (BPO) service providers
• Technology Vendors/Portal Service Providers